S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Twitter executive responsible for content safety resigns after Elon Musk criticism
Slow start to New York's legal pot market leaves farmers holding the bag
NASDAQ:IRIX

IRIDEX (IRIX) Stock Forecast, Price & News

$2.15
-0.01 (-0.46%)
(As of 06/2/2023 ET)
Compare
Today's Range
$2.12
$2.24
50-Day Range
$2.00
$2.43
52-Week Range
$1.96
$3.49
Volume
9,297 shs
Average Volume
12,886 shs
Market Capitalization
$34.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

IRIDEX MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
39.5% Upside
$3.00 Price Target
Short Interest
Healthy
0.40% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.36) to ($0.23) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.47 out of 5 stars

Computer And Technology Sector

547th out of 609 stocks

Electromedical Equipment Industry

20th out of 22 stocks


IRIX stock logo

About IRIDEX (NASDAQ:IRIX) Stock

IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.

Receive IRIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter.

IRIX Stock News Headlines

WARNING TO ALL U.S. INVESTORS
May 16, 2023... The Day That Will Financially Paralyze 181 Million American Investors... Here are 3 steps to prepare yourself >>>
StockNews.com Initiates Coverage on IRIDEX (NASDAQ:IRIX)
Iridex: Q1 Earnings Insights
Iridex Reports First Quarter 2023 Financial Results
StockNews.com Begins Coverage on IRIDEX (NASDAQ:IRIX)
WARNING TO ALL U.S. INVESTORS
May 16, 2023... The Day That Will Financially Paralyze 181 Million American Investors... Here are 3 steps to prepare yourself >>>
IRIDEX (IRIX) Set to Announce Earnings on Thursday
IRIDEX (NASDAQ:IRIX) Coverage Initiated at StockNews.com
Iridex to Present at the 35th Annual Roth Conference
IRIDEX Third Quarter 2022 Earnings: Beats Expectations
See More Headlines

IRIX Price History

IRIX Company Calendar

Last Earnings
3/09/2023
Today
6/04/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:IRIX
Employees
119
Year Founded
1989

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+39.5%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-7,550,000.00
Pretax Margin
-12.55%

Debt

Sales & Book Value

Annual Sales
$57.29 million
Book Value
$0.99 per share

Miscellaneous

Free Float
15,351,000
Market Cap
$34.42 million
Optionable
Not Optionable
Beta
1.23

Social Links


Key Executives

  • David I. Bruce
    President, Chief Executive Officer & Director
  • Patrick Mercer
    Chief Operating Officer
  • Fuad Ahmad
    Chief Financial Officer
  • George R. Marcellino
    Vice President-Clinical Affairs
  • Susan Bruce
    Executive Administrator













IRIX Stock - Frequently Asked Questions

Should I buy or sell IRIDEX stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for IRIDEX in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" IRIX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IRIX, but not buy additional shares or sell existing shares.
View IRIX analyst ratings
or view top-rated stocks.

What is IRIDEX's stock price forecast for 2023?

1 equities research analysts have issued 1-year price targets for IRIDEX's shares. Their IRIX share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 39.5% from the stock's current price.
View analysts price targets for IRIX
or view top-rated stocks among Wall Street analysts.

How have IRIX shares performed in 2023?

IRIDEX's stock was trading at $2.01 on January 1st, 2023. Since then, IRIX stock has increased by 7.0% and is now trading at $2.15.
View the best growth stocks for 2023 here
.

When is IRIDEX's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our IRIX earnings forecast
.

How were IRIDEX's earnings last quarter?

IRIDEX Co. (NASDAQ:IRIX) posted its quarterly earnings data on Thursday, March, 9th. The medical equipment provider reported ($0.07) earnings per share for the quarter, topping the consensus estimate of ($0.11) by $0.04. The medical equipment provider earned $15.20 million during the quarter, compared to the consensus estimate of $15.17 million. IRIDEX had a negative net margin of 12.65% and a negative trailing twelve-month return on equity of 41.04%.

What guidance has IRIDEX issued on next quarter's earnings?

IRIDEX issued an update on its FY 2023 earnings guidance on Friday, May, 26th. The company provided EPS guidance of for the period. The company issued revenue guidance of $57.00 million-$59.00 million, compared to the consensus revenue estimate of $58.06 million.

What is Theodore A. Boutacoff's approval rating as IRIDEX's CEO?

7 employees have rated IRIDEX Chief Executive Officer Theodore A. Boutacoff on Glassdoor.com. Theodore A. Boutacoff has an approval rating of 64% among the company's employees.

What other stocks do shareholders of IRIDEX own?
What is IRIDEX's stock symbol?

IRIDEX trades on the NASDAQ under the ticker symbol "IRIX."

Who are IRIDEX's major shareholders?

IRIDEX's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (2.64%), Isthmus Partners LLC (2.37%), Dimensional Fund Advisors LP (1.29%), Clayton Partners LLC (0.18%) and AMH Equity Ltd (0.17%). Insiders that own company stock include Nandini Devi and Robert Earle Grove.
View institutional ownership trends
.

How do I buy shares of IRIDEX?

Shares of IRIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is IRIDEX's stock price today?

One share of IRIX stock can currently be purchased for approximately $2.15.

How much money does IRIDEX make?

IRIDEX (NASDAQ:IRIX) has a market capitalization of $34.42 million and generates $57.29 million in revenue each year. The medical equipment provider earns $-7,550,000.00 in net income (profit) each year or ($0.45) on an earnings per share basis.

How many employees does IRIDEX have?

The company employs 119 workers across the globe.

How can I contact IRIDEX?

IRIDEX's mailing address is 1212 Terra Bella Avenue, Mountain View CA, 94043. The official website for the company is www.iridex.com. The medical equipment provider can be reached via phone at (650) 940-4700, via email at investors@iridex.com, or via fax at 650-940-4710.

This page (NASDAQ:IRIX) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -